53BP2 Antibodies

Santa Cruz Biotechnology provides a broad selection of 53BP2 monoclonal antibodies for investigating cellular processes. 53BP2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 53BP2 plays a crucial role in DNA damage response and repair, significantly contributing to genomic stability maintenance. The protein regulates cell cycle checkpoints and apoptosis, making it a key focus in cancer research and studies of diseases linked to genomic instability. Understanding 53BP2 function can reveal potential therapeutic strategies for treating various malignancies. Researchers worldwide rely on 53BP2 monoclonal antibodies to advance their studies in cell biology and disease mechanisms. Validated data and consistent performance of 53BP2 monoclonal antibodies enable reliable experimental outcomes. Advanced research techniques and rigorous quality standards ensure dependable results across multiple applications. Santa Cruz Biotechnology monoclonal antibodies for 53BP2 continue to support breakthrough discoveries in cancer research and cellular biology, helping scientists advance their understanding of disease mechanisms.